Lawrence J Hineline Net Worth & Insider Trades
Lawrence J Hineline - SVP Finance CFO, Intra-Cellular Therapies, Inc
What is Lawrence J Hineline's Net Worth?
The current estimated net worth of Intra-Cellular Therapies, Inc's SVP Finance CFO, Lawrence J Hineline, is estimated to be about $34.73M . Lawrence J Hineline owns about 0 unit of Intra-Cellular Therapies, Inc common stock. In the last 9 years at Intra-Cellular Therapies, Inc, Lawrence J Hineline has sold an estimated value of $32.67M worth.
What is Lawrence J Hineline's Past Insider Trading?
Lawrence J Hineline's largest purchase order was 81,854 units , worth over $3.46M on June 16, 2023. Lawrence J Hineline's largest sale order was 175,000 units , worth over $8.33M on December 23, 2021. In total, Lawrence J Hineline has made about 38 transactions over 9 years of their time at Intra-Cellular Therapies, Inc. Lawrence J Hineline usually trades in January, with the busiest year in 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lawrence J Hineline
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Lawrence J Hineline's Salary in 2020?
As SVP Finance CFO of Intra-Cellular Therapies, Inc, Lawrence J Hineline has a total base salary of $463,400 . Lawrence J Hineline received compensation valued at about $2,206,183 in 2020 after becoming SVP Finance CFO. The vast majority of their compensation came in the form of a bonus of $222,432 , stock awards of $1,049,984 , option awards of $449,993 , and other compensation of $20,374 .
What is Lawrence J Hineline's' Mailing Address?
- Mailing address is C/o Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 NY
Intra-Cellular Therapies, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Sharon Mates, Ph.D. | 2020 | $766,800 | $690,120 | $2,799,998 | $1,199,994 | $18,767 | $5,475,679 |
| Sharon Mates, Ph.D. | 2019 | $744,500 | $759,400 | $1,599,996 | $1,600,003 | $20,661 | $4,724,560 |
| Sharon Mates, Ph.D. | 2018 | $722,800 | $585,500 | $1,593,735 | $1,556,410 | $18,024 | $4,476,469 |
| Lawrence J. Hineline | 2020 | $463,400 | $222,432 | $1,049,984 | $449,993 | $20,374 | $2,206,183 |
| Lawrence J. Hineline | 2019 | $449,900 | $225,000 | $749,988 | $749,995 | $18,648 | $2,193,531 |
| Lawrence J. Hineline | 2018 | $424,400 | $203,700 | $749,986 | $732,430 | $17,292 | $2,127,808 |
| Suresh Durgam, M.D. | 2020 | $448,575 | $274,400 | $599,984 | $599,997 | $7,385 | $1,930,341 |
| Michael I. Halstead | 2020 | $512,000 | $320,000 | $1,119,985 | $479,990 | $17,931 | $2,449,906 |
| Michael I. Halstead | 2019 | $497,100 | $323,100 | $749,988 | $749,995 | $17,270 | $2,337,453 |
| Michael I. Halstead | 2018 | $469,000 | $225,100 | $749,986 | $732,430 | $16,680 | $2,193,196 |
| Mark Neumann | 2020 | $518,900 | $324,312 | $1,119,985 | $479,990 | $130,085 | $2,573,272 |
| Mark Neumann | 2019 | $503,800 | $277,100 | $799,991 | $799,997 | $133,449 | $2,514,337 |
| Mark Neumann | 2018 | $106,090 | $245,500 | $749,995 | $749,990 | $25,124 | $1,876,699 |
| Andrew Satlin, M.D. | 2020 | $480,634 | $0 | $1,119,985 | $479,990 | $20,585 | $2,101,194 |
| Andrew Satlin, M.D. | 2019 | $515,000 | $360,500 | $874,997 | $874,996 | $19,332 | $2,644,825 |
| Andrew Satlin, M.D. | 2018 | $500,000 | $300,000 | $0 | $0 | $11,792 | $811,792 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm
What are Intra-Cellular Therapies, Inc's Past Insider Trades?
Intra-Cellular Therapies, Inc's most recent insider trade came on November 14, 2023 by Michael Halstead who sold 50,000 units worth $2.69M . In the last 9 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $142.39M and bought an estimated value of $70.48M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director, Rory Riggs, Director, and Robert Nostrand Van, Director .
Intra-Cellular Therapies, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||